A gut microbe secretes macrophage-targeting factors, rendering the intestinal layer vulnerable to ulcerative colitis, ...

The discovery that a toxin made by bacteria found in dirty water might help trigger ulcerative colitis could lead to new ...

Bottom Line: Adding the investigational antibody ianalumab (VAY736) to ibrutinib (Imbruvica) allowed some patients with chronic lymphocytic leukemia (CLL) to discontinue daily therapy and potentially ...

The Imagine the Cure LA Gala: A Masquerade Under the Stars helped raise money for the Crohn's and Colitis Foundation. Tropical Storm Melissa update as "catastrophic" conditions to hit in hours ...

Ulcerative colitis is a type of inflammatory bowel disease (IBD) that causes inflammation of the colon, and leads to symptoms such as fatigue, abdominal pain, and cramping. There is currently no cure ...

Compared with placebo, significantly greater proportions of patients treated with Tremfya achieved clinical remission and endoscopic improvement. HealthDay News — The US Food and Drug Administration ...

At a very young age, Maxwell Huffman knew that he absorbed the world around him differently than most of his classmates. He was diagnosed with autism as a teenager, and nearly 20 years later, Huffman ...

With a fresh endorsement from the FDA, Johnson & Johnson has rounded out Tremfya’s presence in inflammatory bowel disease (IBD) and, in doing so, achieved a first for the IL-23 inhibitor drug class.

Gene therapies for rare diseases are frequently developed then discarded by drug companies because they can’t afford to produce the treatment for more patients. Gene therapies for rare diseases are ...

Various factors may increase risk for microscopic colitis — NSAIDs among them. The diagnosis of MC is complicated by its need for well-trained general practitioners, gastroenterologists with ...

Vedanta Biosciences said a recent trial of its potential treatment for mild-to-moderate ulcerative colitis, a chronic inflammatory bowel disease, failed to reach its primary endpoint. The ...